Sabaa Pharmaceutical's shareholders approve capital raise via bonus issue
Sabaa Pharmaceutical's profit leaps 76% in 2020 initial results
WHO ‘strongly’ against hydroxychloroquine use for COVID-19 prevention
At our state-of-the-art manufacturing plant, Sabaa is home for a number of Egyptian pharmaceutical companies for which we manufacture.
We promise the best quality, prices and service to our clients.
You can a get a quotation below:
© 2021 - 2024 All Rights Reserved. Designed & Developed By Spark Systems